RecallDepth
Class I Terminated

Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic Water for Injection, USP (1.1% benzyl alcohol), Manufactured by Hospira, Inc., for Genentech, Inc., South San Francisco, CA 94080-4990, NDC 50242-903-69; and 1 Reconstitution Instructions per kit; Investigation Use only, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990.

Company
Genentech, Inc.
Recall Initiated
July 30, 2012
Posted
January 30, 2013
Recall Number
D-135-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,140 kits
Firm Location
South San Francisco, CA, United States

Reason for Recall

Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials that were packed with Trastuzumab Kits for investigational use has the potential to contain glass particulates.

Distribution

Nationwide

Lot / Code Info

Lot #: 454138, Exp 07/14 (containing Trastuzumab Lot #: 886618, Exp 12/14; and Bacteriostatic Water for Injection, USP Lot #: 08-368-DK-01, Exp 07/14)

More recalls by Genentech, Inc.

View all recalls by this company →

Other recent Class I Drug recalls